CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Omnicell Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Omnicell Inc
4220 NORTH FREEWAY
Phone: (650) 251-6100p:650 251-6100 FORT WORTH, TX  76137  United States Ticker: OMCLOMCL

Business Summary
Omnicell, Inc. is a provider of medication management solutions and adherence tools for health systems and pharmacies. The Company is focused on transforming pharmacy care through outcomes-centric innovation designed to optimize clinical and business outcomes across all settings of care through a portfolio of robotics, smart devices, intelligent software, and services. Its point of care automation solutions is designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. The Company’s XT Series automated dispensing systems for medications and supplies, which are used in nursing units and other clinical areas of the hospital, are designed to support workflows specific to each area of the hospital, with various software and hardware options. For the operating room, the Company also offer specialized automated dispensing systems.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/202312/31/2023YesYes-YesYes

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board, President, Chief Executive Officer Randall A.Lipps 65 10/16/2002 9/1/1992
Chief Financial Officer, Executive Vice President Nchacha E.Etta 6/1/2023 6/1/2023
Senior Vice President, Chief Accounting Officer, Corporate Controller Joseph B.Spears 62 1/1/2019 1/30/2018
6 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
MTS Medication Technologies, Inc. 2003 Gandy Boulevard North St. Petersburg FL United States
Ateb, Inc. 11125 Forest Pines Drive Raleigh NC United States
Aesynt, Inc. 500 Cranberry Woods Drive Cranberry Township PA United States
ReCept Pharmacy, LLC 1620 W. Northwest Highway Grapevine TX United States
MarkeTouch Media, Inc. 5718 Westheimer Road Houston TX United States

Business Names
Business Name
340B
Aesynt Holding Cooperatief U.A.
FDS Amplicare
23 additional Business Names available in full report.

General Information
Number of Employees: 3,650 (As of 12/31/2023)
Outstanding Shares: 45,923,492 (As of 3/28/2024)
Shareholders: 76
Stock Exchange: NASD
Federal Tax Id: 943166458
Fax Number: (650) 251-6266
Email Address: info@Omnicell.com


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, April 19, 2024